Pediatric Outcomes in Transplant: PersOnaliSing Immunosuppression To ImproVe Efficacy (POSITIVE Study): The Collaboration and Design of a National Transplant Precision Medicine Program
Tanya Papaz(University of Toronto), Seema Mital(University of Toronto), Tal Schechter(Hospital for Sick Children), Bethany J. Foster(Montreal Children's Hospital), Lorraine Hamiwka(The University of Sydney), Sandar Min(Hospital for Sick Children), Tom Blydt‐Hansen(University of British Columbia), Simon Urschel(Stollery Children's Hospital), Patricia E. Birk(Health Sciences Centre), Donna A. Wall(University of Manitoba), Upton Allen(University of Toronto), Véronique Phan(Centre Hospitalier Universitaire Sainte-Justine)
Cited by 13
Related Papers
Contribution of rare inherited and de novo variants in 2,871 congenital heart disease probands
|Nature Genetics|2017|945
De novo mutations in congenital heart disease with neurodevelopmental and other congenital anomalies
|Science|2015|905
Canadian Cardiovascular Society 2009 Consensus Conference on the management of adults with congenital heart disease: Executive summary
|Canadian Journal of Cardiology|2010|201
Patient satisfaction and health‐related quality of life after autologous tissue breast reconstruction
|Cancer|2011|192
Intrinsic Endocardial Defects Contribute to Hypoplastic Left Heart Syndrome
|Cell stem cell|2020|171